drugset / Trial / NCT00600093
Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether administrating of Amantadine (a dopamine agonist) to patients suffering from Parkinson disease during the perioperative period is safe, and to asses potential benefits of this treatment.
Timeline
- Start
- 2008-01
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amantadine | Unknown | 200 mg | Intravenous |